FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Philip Castle

Research Profile

Disorders

Living Beings

Chemicals & Drugs

DNA, Viral

Procedures

Anatomy

Cervix Uteri

Concepts & Ideas

Geographic Areas

Costa Rica

Physiology

Genotype

Co-author Network

Publications

TOP 3
Hormuzd A Katki; Philip E Castle; Li C Cheung; Barbara Fetterman; Julia C Gage; Thomas Lorey; Nancy E Poitras; Tina Raine-Bennett; Mark Schiffman; Walter K Kinney
Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management.
Hormuzd A Katki; Philip E Castle; Li C Cheung; Barbara Fetterman; Julia C Gage; Thomas Lorey; Nancy E Poitras; Tina Raine-Bennett; Mark Schiffman; Walter K Kinney
Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less.
Hormuzd A Katki; Philip E Castle; Li C Cheung; Barbara Fetterman; Julia C Gage; Thomas Lorey; Nancy E Poitras; Tina Raine-Bennett; Mark Schiffman; Walter K Kinney
Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Philip Castle (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Hormuzd A Katki; Philip E Castle; Li C Cheung; Barbara Fetterman; Julia C Gage; Thomas Lorey; Nancy E Poitras; Tina Raine-Bennett; Mark Schiffman; Walter K Kinney
Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management.
Journal of lower genital tract disease 2013;17(5 Suppl 1):S78-84.
2013: Hormuzd A Katki; Philip E Castle; Li C Cheung; Barbara Fetterman; Julia C Gage; Thomas Lorey; Nancy E Poitras; Tina Raine-Bennett; Mark Schiffman; Walter K Kinney
Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less.
Journal of lower genital tract disease 2013;17(5 Suppl 1):S69-77.
2013: Hormuzd A Katki; Philip E Castle; Li C Cheung; Barbara Fetterman; Julia C Gage; Thomas Lorey; Nancy E Poitras; Tina Raine-Bennett; Mark Schiffman; Walter K Kinney
Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years.
Journal of lower genital tract disease 2013;17(5 Suppl 1):S64-8.
2013: Hormuzd A Katki; Philip E Castle; Li C Cheung; Barbara Fetterman; Julia C Gage; Thomas Lorey; Nancy E Poitras; Tina Raine-Bennett; Mark Schiffman; Walter K Kinney
Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive.
Journal of lower genital tract disease 2013;17(5 Suppl 1):S56-63.
2013: Hormuzd A Katki; Philip E Castle; Li C Cheung; Barbara Fetterman; Julia C Gage; Thomas Lorey; Nancy E Poitras; Tina Raine-Bennett; Mark Schiffman; Walter K Kinney
Five-year risks of CIN 3+ and cervical cancer among women with HPV-positive and HPV-negative high-grade Pap results.
Journal of lower genital tract disease 2013;17(5 Suppl 1):S50-5.
2013: Hormuzd A Katki; Philip E Castle; Li C Cheung; Barbara Fetterman; Julia C Gage; Thomas Lorey; Nancy E Poitras; Tina Raine-Bennett; Mark Schiffman; Walter K Kinney
Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results.
Journal of lower genital tract disease 2013;17(5 Suppl 1):S43-9.
2013: Hormuzd A Katki; Philip E Castle; Li C Cheung; Barbara Fetterman; Julia C Gage; Thomas Lorey; Nancy E Poitras; Tina Raine-Bennett; Mark Schiffman; Walter K Kinney
Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results.
Journal of lower genital tract disease 2013;17(5 Suppl 1):S36-42.
2013: Hormuzd A Katki; Philip E Castle; Li C Cheung; Barbara Fetterman; Julia C Gage; Thomas Lorey; Nancy E Poitras; Tina Raine-Bennett; Mark Schiffman; Walter K Kinney
Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines.
Journal of lower genital tract disease 2013;17(5 Suppl 1):S28-35.
2013: Brandon J Lamere; Thomas Lorey; Nancy Poitras; Philip E Castle; Barbara Fetterman; Walter Kinney; Jen Shieh; Mark Stanley; Mark Schiffman
A study of borderline positive Hybrid Capture 2 tests in the Kaiser Permanente Northern California cervical screening program: evidence against retesting.
Journal of virological methods 2013;189(1):77-9.
2013: Yaoyao Guan; Roslyn Howard; Belinda Li; You-Lin Qiao; Shaoming Wang; Yolanda J Eby; Changyan Feng; Patti Gravitt; Philip E Castle
Agreement for HPV genotyping detection between self-collected specimens on a FTA cartridge and clinician-collected specimens.
Journal of virological methods 2013;189(1):167-71.
2013: Vikrant V Sahasrabuddhe; Lauren M Schwartz; Scott Dahai Tang; Diane Tokugawa; Sylvia Borgonovo; Sean Boyle; Philip E Castle; Teresa M Darragh; Barbara Fetterman; Stephen Follansbee; Julia C Gage; Brandon J LaMere; Thomas S Lorey; Mark Sadorra; Nicolas Wentzensen
Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men.
The Journal of infectious diseases 2013;207(3):392-401.
2013: Philip E Castle; Teresa M Darragh; Barbara Fetterman; Stephen Follansbee; Julia C Gage; Brandon LaMere; Thomas S Lorey; Ana Cecilia Rodriguez; Lauren M Schwartz; Diane Tokugawa; Sylvia Borgonovo; Nicolas Wentzensen
A comparison of human papillomavirus genotype-specific DNA and E6/E7 mRNA detection to identify anal precancer among HIV-infected men who have sex with men.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013;22(1):42-9.
2012: Julia C Gage; Martha Hutchinson; Mary Reilly; Akinfolarin C Adepiti; Kayode O Ajenifuja; Laura Bell; Robert D Burk; Philip E Castle; Paul S Eder; Claire Eklund; Niwashin Shrestha; Mark Stoler; Sholom Wacholder; Nicolas Wentzensen; Mark Schiffman
Effectiveness of a simple rapid human papillomavirus DNA test in rural Nigeria.
International journal of cancer. Journal international du cancer 2012;131(12):2903-9.
2012: YaoYao Guan; Belinda Li; Xue Li; Philip E Castle; Puwa Ci; Changyan Feng; Patti Gravitt; Shaoming Wang; You-Lin Qiao
A cross-sectional study on the acceptability of self-collection for HPV testing among women in rural China.
Sexually transmitted infections 2012;88(7):490-4.
2012: Gypsyamber D'Souza; Alexandra M Levine; Howard Minkoff; Joel M Palefsky; Kathryn Anastos; Robert D Burk; Philip E Castle; Christine Colie; Xiaonan Xue; Ye Zhong; L Stewart Massad; D Heather Watts; Howard D Strickler
Cervicovaginal human papillomavirus (HPV)-infection before and after hysterectomy: evidence of different tissue tropism for oncogenic and nononcogenic HPV types in a cohort of HIV-positive and HIV-negative women.
International journal of cancer. Journal international du cancer 2012;131(6):1472-8.
2012: Helen Dinkelspiel; Barbara Fetterman; Walter Kinney; Thomas Lorey; Nancy Poitras; J Thomas Cox; Philip E Castle
Screening history preceding a diagnosis of cervical cancer in women age 65 and older.
Gynecologic oncology 2012;126(2):203-6.
2012: Debbie Saslow; Mark Schiffman; Diane Solomon; Mark Spitzer; Mark H Stoler; Alan G Waxman; Nicolas Wentzensen; David C Wilbur; Joanna M Cain; Philip E Castle; David Chelmow; Levi S Downs; Eduardo L Franco; Francisco A R Garcia; W Lawson Herschel; Abbe Herzig; Maureen Killackey; Jane J Kim; Walter Kinney; Shalini L Kulasingam; Herschel W Lawson; Ann T Moriarty; Anna-Barbara Moscicki; Evan R Myers; Jeffrey Waldman
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.
Journal of lower genital tract disease 2012;16(3):175-204.
2012: Debbie Saslow; Mark Schiffman; Diane Solomon; Mark Spitzer; Mark H Stoler; Alan G Waxman; Nicolas Wentzensen; David C Wilbur; Joanna Cain; Philip E Castle; Levi S Downs; Eduardo L Franco; Francisco A R Garcia; Maureen Killackey; Shalini L Kulasingam; Herschel W Lawson; Ann T Moriarty; Anna-Barbara Moscicki; Evan R Myers
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.
CA: a cancer journal for clinicians 2012;62(3):147-72.
2012: Debbie Saslow; Mark Schiffman; Diane Solomon; Mark Spitzer; Mark H Stoler; Alan G Waxman; Nicolas Wentzensen; David C Wilbur; Joanna Cain; Philip E Castle; Levi S Downs; Eduardo L Franco; Francisco A R Garcia; Maureen Killackey; Shalini L Kulasingam; Herschel W Lawson; Ann T Moriarty; Anna-Barbara Moscicki; Evan R Myers
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.
American journal of clinical pathology 2012;137(4):516-42.
2012: Hormuzd A Katki; Yan Li; David W Edelstein; Philip E Castle
Estimating the agreement and diagnostic accuracy of two diagnostic tests when one test is conducted on only a subsample of specimens.
Statistics in medicine 2012;31(5):436-48.
2012: Julia C Gage; Randi Kail; Walter Kinney; Brandon J Lamere; Thomas Lorey; Mark Sadorra; Mark Schiffman; Carrie Aldrich; Philip E Castle; Barbara Fetterman
Comparison of the cobas Human Papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests.
Journal of clinical microbiology 2012;50(1):61-5.
2011: Julia C Gage; Patti Gravitt; Edward E Partridge; Alfio Rausa; Isabel Scarinci; Mark Schiffman; Sholom Wacholder; Philip E Castle
Comparative performance of human papillomavirus DNA testing using novel sample collection methods.
Journal of clinical microbiology 2011;49(12):4185-9.
2011: Hannah P Yang; Laura Bell; Paul S Eder; Julia C Gage; Lori Kobayashi; Delson Merisier; Sameera Rangwala; Niwashin Shrestha; David K Walmer; Philip E Castle
A pilot analytic study of a research-level, lower-cost human papillomavirus 16, 18, and 45 test.
Journal of virological methods 2011;176(1-2):112-4.
2011: Hormuzd A Katki; Walter K Kinney; Thomas Lorey; Nancy E Poitras; Mark Schiffman; Sholom Wacholder; Li Cheung; Franklin Demuth; Barbara Fetterman; Philip E Castle
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.
The lancet oncology 2011;12(7):663-72.
2011: Mark Schiffman; David R Scott; Mark E Sherman; Sholom Wacholder; Nicolas Wentzensen; Philip E Castle; Andrew G. Glass; Peter Kirk; Attila T Lorincz; Brenda B Rush; Greg Rydzak; Julie Buckland; Robert D Burk
A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(7):1398-409.
2011: Philip E Castle; Alfio Rausa; Tameka Walls; Patti Gravitt; Edward E Partridge; Vanessa Olivo; Shelley Niwa; Kerry Grace Morrissey; Laura Tucker; Hormuzd A Katki; Isabel Scarinci
Comparative community outreach to increase cervical cancer screening in the Mississippi Delta.
Preventive medicine 2011;52(6):452-5.
2011: Walter Kinney; Barbara Fetterman; J Thomas Cox; Thomas Lorey; Tracy Flanagan; Philip E Castle
Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practice.
Gynecologic oncology 2011;121(2):309-13.
2011: Philip E Castle; Ana Cecilia Rodríguez; Robert D Burk; Rolando Herrero; Sholom Wacholder; Allan Hildesheim; Jorge Morales; Greg Rydzak; Mark Schiffman
Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer.
The Journal of infectious diseases 2011;203(6):814-22.
2011: Philip E Castle
Do selective estrogen receptor modulators treat cervical precancer and cancer? Time to pool data from relevant trials.
International journal of cancer. Journal international du cancer 2011;128(4):997-8.
2011: Julia C Gage; Arpita Ghosh; Niels Grabe; Patti Gravitt; Bernd Lahrmann; Nicolas Wentzensen; Sylvia Borgonovo; Stephen Follansbee; Philip E Castle
A comparison of dacron versus Flocked nylon swabs for anal cytology specimen collection.
Acta cytologica 2011;55(4):364-7.
2011: Ramey D Littell; Walter Kinney; Barbara Fetterman; J Thomas Cox; Ruth Shaber; Nancy Poitras; Thomas Lorey; Philip E Castle
Risk of cervical precancer and cancer in women aged 30 years and older with an HPV-negative low-grade squamous intraepithelial lesion screening result.
Journal of lower genital tract disease 2011;15(1):54-9.
2010: Long Fu Xi; Laura A Koutsky; Philip E Castle; Zoe R Edelstein; Ayaka Hulbert; Mark Schiffman; Nancy B Kiviat
Human papillomavirus type 16 variants in paired enrollment and follow-up cervical samples: implications for a proper understanding of type-specific persistent infections.
The Journal of infectious diseases 2010;202(11):1667-70.
2010: Julia C Gage; Máire A Duggan; Jill G Nation; Song Gao; Philip E Castle
Detection of cervical cancer and its precursors by endocervical curettage in 13,115 colposcopically guided biopsy examinations.
American journal of obstetrics and gynecology 2010;203(5):481.e1-9.
2010: Julia C Gage; Philip E Castle
Preventing cervical cancer globally by acting locally: if not now, when?
Journal of the National Cancer Institute 2010;102(20):1524-7.
2010: Mary T Galgano; Philip E Castle; Kristen A Atkins; William K Brix; Sarah R Nassau; Mark H Stoler
Using biomarkers as objective standards in the diagnosis of cervical biopsies.
The American journal of surgical pathology 2010;34(8):1077-87.
2010: Walter Kinney; Mark H Stoler; Philip E Castle
Special commentary: patient safety and the next generation of HPV DNA tests.
American journal of clinical pathology 2010;134(2):193-9.
2010: Philip E Castle; J Bulten; M Confortini; P Klinkhamer; A Pellegrini; (Al)bert G Siebers; G Ronco; Marc Arbyn
Age-specific patterns of unsatisfactory results for conventional Pap smears and liquid-based cytology: data from two randomised clinical trials.
BJOG : an international journal of obstetrics and gynaecology 2010;117(9):1067-73.
2010: Philip E Castle; Mark Schiffman; Cosette M Wheeler; Nicolas Wentzensen; Patti Gravitt
Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(7):1675-81.
2010: Julia C Gage; Mark Schiffman; Diane Solomon; Cosette M Wheeler; Philip E Castle
Comparison of measurements of human papillomavirus persistence for postcolposcopic surveillance for cervical precancerous lesions.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(7):1668-74.
2010: Philip E Castle
Screening: HPV testing for cervical cancer: the good, the bad, and the ugly.
Nature reviews. Clinical oncology 2010;7(7):364-5.
2010: Philip E Castle; J Daniel Carreon
Practice improvement in cervical screening and management: symposium on management of cervical abnormalities in adolescents and young women.
Journal of lower genital tract disease 2010;14(3):238-340; author reply 240.
2010: Mark Schiffman; Ana Cecilia Rodriguez; Zigui Chen; Sholom Wacholder; Rolando Herrero; Allan Hildesheim; Rob DeSalle; Brian Befano; Kai Yu; Mahboobeh Safaeian; Mark E Sherman; Jorge Morales; Diego Guillen; Mario Alfaro; Martha Hutchinson; Diane Solomon; Philip E Castle; Robert D Burk
A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia.
Cancer research 2010;70(8):3159-69.
2010: Gaea Moore; Barbara Fetterman; J Thomas Cox; Nancy Poitras; Thomas Lorey; Walter Kinney; Philip E Castle
Lessons from practice: risk of CIN 3 or cancer associated with an LSIL or HPV-positive ASC-US screening result in women aged 21 to 24.
Journal of lower genital tract disease 2010;14(2):97-102.
2010: Philip E Castle; Hormuzd A Katki
Benefits and risks of HPV testing in cervical cancer screening.
The lancet oncology 2010;11(3):214-5.
2010: Philip E Castle; Barbara Fetterman; Nancy Poitras; Thomas Lorey; Ruth Shaber; Walter Kinney
Relationship of atypical glandular cell cytology, age, and human papillomavirus detection to cervical and endometrial cancer risks.
Obstetrics and gynecology 2010;115(2 Pt 1):243-8.
2010: Delphine Maucort-Boulch; Martyn Plummer; Philip E Castle; Franklin Demuth; Mahboobeh Safaeian; Cosette M Wheeler; Mark Schiffman
Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology.
International journal of cancer. Journal international du cancer 2010;126(3):684-91.
2010: Philip E Castle; Mark Schiffman; Cosette M Wheeler; Nicolas Wentzensen; Patti Gravitt
Impact of improved classification on the association of human papillomavirus with cervical precancer.
American journal of epidemiology 2010;171(2):155-63.
2009: Hormuzd A Katki; Sholom Wacholder; Diane Solomon; Philip E Castle; Mark Schiffman
Risk estimation for the next generation of prevention programmes for cervical cancer.
The lancet oncology 2009;10(11):1022-3.
2009: Philip E Castle; Mark Sadorra; Tiffany Lau; Carrie Aldrich; Francisco A R Garcia; Janet R Kornegay
Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping.
Journal of clinical microbiology 2009;47(10):3344-7.
2009: Philip E Castle; Ana Cecilia Rodríguez; Robert D Burk; Rolando Herrero; Allan Hildesheim; Diane Solomon; Mark E Sherman; Jose Jeronimo; Mario Alfaro; Jorge Morales; Diego Guillén; Martha L Hutchinson; Sholom Wacholder; Mark Schiffman
Neither one-time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer.
International journal of cancer. Journal international du cancer 2009;125(7):1649-56.
2009: J Thomas Cox; Ann T Moriarty; Philip E Castle
Commentary on statement on human papillomavirus test utilization.
Archives of pathology & laboratory medicine 2009;133(8):1192-4.
2009: Philip E Castle; Barbara Fetterman; Israh Akhtar; Mujtaba Husain; Michael A Gold; Richard Guido; Andrew G. Glass; Walter Kinney
Age-appropriate use of human papillomavirus vaccines in the U.S.
Gynecologic oncology 2009;114(2):365-9.
2009: John Thomas Cox; Ann T Moriarty; Philip E Castle
Commentary on: Statement on HPV DNA test utilization.
Journal of lower genital tract disease 2009;13(3):131-4.
2009: Philip E Castle; Aimée R Kreimer; Sholom Wacholder; Cosette M Wheeler; Laura A Koutsky; Greg Rydzak; Dennis W Buckman; Barry Graubard; Mark Schiffman
Influence of loop electrosurgical excision procedure on subsequent acquisition of new human papillomavirus infections.
The Journal of infectious diseases 2009;199(11):1612-20.
2009: Nicolas Wentzensen; Patti Gravitt; Diane Solomon; Cosette M Wheeler; Philip E Castle
A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(5):1341-9.
2009: Mahboobeh Safaeian; Mark Schiffman; Julia Gage; Diane Solomon; Cosette M Wheeler; Philip E Castle
Detection of precancerous cervical lesions is differential by human papillomavirus type.
Cancer research 2009;69(8):3262-6.
2009: Philip E Castle; Barbara Fetterman; Nancy Poitras; Thomas Lorey; Ruth Shaber; Walter Kinney
Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting.
Obstetrics and gynecology 2009;113(3):595-600.
2009: Philip E Castle; Ana Cecilia Rodríguez; Robert D Burk; Rolando Herrero; Sholom Wacholder; Mario Alfaro; Jorge Morales; Diego Guillen; Mark E Sherman; Diane Solomon; Mark Schiffman
Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study.
BMJ (Clinical research ed.) 2009;339():b2569.
2009: Philip E Castle
The evolving definition of carcinogenic human papillomavirus.
Infectious agents and cancer 2009;4():7.
2008: Philip E Castle; Carolina Porras; Wim Quint; Ana Cecilia Rodriguez; Mark Schiffman; Patti Gravitt; Paula González; Hormuzd A Katki; Sandra Silva; Enrique Freer; Leen-Jan van Doorn; Silvia Jiménez; Rolando Herrero; Allan Hildesheim
Comparison of two PCR-based human papillomavirus genotyping methods.
Journal of clinical microbiology 2008;46(10):3437-45.
2008: Philip E Castle; J Thomas Cox; Mark Schiffman; Cosette M Wheeler; Diane Solomon
Factors influencing histologic confirmation of high-grade squamous intraepithelial lesion cytology.
Obstetrics and gynecology 2008;112(3):637-45.
2008: Philip E Castle; Diane Solomon; Cosette M Wheeler; Patti Gravitt; Sholom Wacholder; Mark Schiffman
Human papillomavirus genotype specificity of hybrid capture 2.
Journal of clinical microbiology 2008;46(8):2595-604.
2008: Brandon J LaMere; Renee Howell; Barbara Fetterman; Jen Shieh; Philip E Castle
Impact of 6-month frozen storage of cervical specimens in alkaline buffer conditions on human papillomavirus genotyping.
Journal of virological methods 2008;151(2):298-300.
2008: Philip E Castle
Invited commentary: is monitoring of human papillomavirus infection for viral persistence ready for use in cervical cancer screening?
American journal of epidemiology 2008;168(2):138-44; discussion 145-8.
2008: Patti Gravitt; Mark Schiffman; Diane Solomon; Cosette M Wheeler; Philip E Castle
A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(5):1248-54.
2008: Ana Cecilia Rodríguez; Mark Schiffman; Rolando Herrero; Sholom Wacholder; Allan Hildesheim; Philip E Castle; Diane Solomon; Robert D Burk
Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.
Journal of the National Cancer Institute 2008;100(7):513-7.
2008: Philip E Castle; J Thomas Cox; Jose Jeronimo; Diane Solomon; Cosette M Wheeler; Patti Gravitt; Mark Schiffman
An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS).
Obstetrics and gynecology 2008;111(4):847-56.
2008: Philip E Castle
The potential utility of HPV genotyping in screening and clinical management.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(1):83-95.
2008: Philip E Castle; Mario Sideri; Jose Jeronimo; Diane Solomon; Mark Schiffman
Risk assessment to guide the prevention of cervical cancer.
Journal of lower genital tract disease 2008;12(1):1-7.
2008: Philip E Castle; Patti Gravitt; Diane Solomon; Cosette M Wheeler; Mark Schiffman
Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study.
Journal of clinical microbiology 2008;46(1):109-17.
2008: J Mariategui; C Santos; L Taxa; Jose Jeronimo; Philip E Castle
Comparison of depth of necrosis achieved by CO2- and N2O-cryotherapy.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2008;100(1):24-6.
2007: Mahboobeh Safaeian; Diane Solomon; Philip E Castle
Cervical cancer prevention--cervical screening: science in evolution.
Obstetrics and gynecology clinics of North America 2007;34(4):739-60, ix.
2007: Brandon J LaMere; Janet R Kornegay; Barbara Fetterman; Mark Sadorra; Jen Shieh; Philip E Castle
Human papillomavirus genotyping after denaturation of specimens for Hybrid Capture 2 testing: feasibility study for the HPV persistence and progression cohort.
Journal of virological methods 2007;146(1-2):80-5.
2007: Philip E Castle; Ana Cecilia Rodriguez; Carolina Porras; Rolando Herrero; Mark Schiffman; Paula Gonzalez; Allan Hildesheim; Robert D Burk
A comparison of cervical and vaginal human papillomavirus.
Sexually transmitted diseases 2007;34(11):849-55.
2007: M Margaret Pratt; Paul Sirajuddin; Miriam C Poirier; Mark Schiffman; Andrew G. Glass; David R Scott; Brenda B Rush; Ofelia A Olivero; Philip E Castle
Polycyclic aromatic hydrocarbon-DNA adducts in cervix of women infected with carcinogenic human papillomavirus types: an immunohistochemistry study.
Mutation research 2007;624(1-2):114-23.
2007: Jose Jeronimo; L Stewart Massad; Philip E Castle; Sholom Wacholder; Mark Schiffman
Interobserver agreement in the evaluation of digitized cervical images.
Obstetrics and gynecology 2007;110(4):833-40.
2007: Philip E Castle; Mario Sideri; Jose Jeronimo; Diane Solomon; Mark Schiffman
Risk assessment to guide the prevention of cervical cancer.
American journal of obstetrics and gynecology 2007;197(4):356.e1-6.
2007: Mark Schiffman; Philip E Castle; Jose Jeronimo; Ana Cecilia Rodriguez; Sholom Wacholder
Human papillomavirus and cervical cancer.
Lancet 2007;370(9590):890-907.
2007: Philip E Castle; Janel Dockter; Cristina Giachetti; Francisco A R Garcia; Mary Kay McCormick; Amy L Mitchell; E Blair Holladay; Daniel P Kolk
A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(9):2599-605.
2007: Philip E Castle; Mark H Stoler; Diane Solomon; Mark Schiffman
The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report.
American journal of clinical pathology 2007;127(5):805-15.
2007: Philip E Castle; Mark Sadorra; Francisco A R Garcia; Allison P Cullen; Attila T Lorincz; Amy L Mitchell; Denise Whitby; Ronald Chuke; Janet R Kornegay
Mouthwash as a low-cost and safe specimen transport medium for human papillomavirus DNA testing of cervicovaginal specimens.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(4):840-3.
2007: Yancy Seamans; Charlie Loesel; Jose Jeronimo; John Sellors; Philip E Castle
Effect of cough technique and cryogen gas on temperatures achieved during simulated cryotherapy.
BMC women's health 2007;7():16.
2007: Debbie Saslow; Philip E Castle; J Thomas Cox; Diane D Davey; Mark Einstein; Daron Gale Ferris; Sue J Goldie; Diane M Harper; Walter Kinney; Anna-Barbara Moscicki; Kenneth L Noller; Cosette M Wheeler; Terri Ades; Kimberly S Andrews; Mary K Doroshenk; Kelly Green Kahn; Christy Schmidt; Omar Shafey; Robert Smith; Edward E Partridge; Francisco Garcia
American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors.
CA: a cancer journal for clinicians 2007;57(1):7-28.
2007: Aimée R Kreimer; Hormuzd A Katki; Mark Schiffman; Cosette M Wheeler; Philip E Castle
Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(1):11-6.
2006: Philip E Castle; Mark Schiffman; Andrew G. Glass; Brenda B Rush; David R Scott; Sholom Wacholder; Anne Dunn; Robert D Burk
Human papillomavirus prevalence in women who have and have not undergone hysterectomies.
The Journal of infectious diseases 2006;194(12):1702-5.
2006: Philip E Castle; Mark Sadorra; Francisco Garcia; E Blair Holladay; Janet R Kornegay
Pilot study of a commercialized human papillomavirus (HPV) genotyping assay: comparison of HPV risk group to cytology and histology.
Journal of clinical microbiology 2006;44(11):3915-7.
2006: Mark E Sherman; Philip E Castle; Diane Solomon
Cervical cytology of atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H): characteristics and histologic outcomes.
Cancer 2006;108(5):298-305.
2006: Melinda Butsch Kovacic; Philip E Castle; Rolando Herrero; Mark Schiffman; Mark E Sherman; Sholom Wacholder; Ana Cecilia Rodriguez; Martha L Hutchinson; M Concepcion Bratti; Allan Hildesheim; Jorge Morales; Mario Alfaro; Robert D Burk
Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality.
Cancer research 2006;66(20):10112-9.
2006: Henry C Kitchener; Philip E Castle; J Thomas Cox
Chapter 7: Achievements and limitations of cervical cytology screening.
Vaccine 2006;24 Suppl 3():S3/63-70.
2006: Philip E Castle; Asma Aftab; Gilbert Saint Jean; Luis Mendez
Detection of carcinogenic human papillomavirus in specimens collected with a novel self-sampling device.
Journal of clinical microbiology 2006;44(6):2158-9.
2006: Aimée R Kreimer; Richard S Guido; Diane Solomon; Mark Schiffman; Sholom Wacholder; Jose Jeronimo; Cosette M Wheeler; Philip E Castle
Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(5):908-14.
2006: Philip E Castle; Jose Jeronimo; Mark Schiffman; Rolando Herrero; Ana Cecilia Rodríguez; M Concepcion Bratti; Allan Hildesheim; Sholom Wacholder; L Rodney Long; Leif Neve; Ruth Pfeiffer; Robert D Burk
Age-related changes of the cervix influence human papillomavirus type distribution.
Cancer research 2006;66(2):1218-24.
2005: Philip E Castle; Joan L Walker; Mark Schiffman; Cosette M Wheeler
Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology.
International journal of cancer. Journal international du cancer 2005;117(6):1007-12.
2005: Philip E Castle; Raheela Ashfaq; Faryal Ansari; Carolyn Y Muller
Immunohistochemical evaluation of heat shock proteins in normal and preinvasive lesions of the cervix.
Cancer letters 2005;229(2):245-52.
2005: Mark Schiffman; Philip E Castle
The promise of global cervical-cancer prevention.
The New England journal of medicine 2005;353(20):2101-4.
2005: Mark Schiffman; Cosette M Wheeler; Abhijit Dasgupta; Diane Solomon; Philip E Castle
A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal papanicolaou smears.
American journal of clinical pathology 2005;124(5):722-32.
2005: Ruth M Pfeiffer; Philip E Castle
With or without a gold standard.
Epidemiology (Cambridge, Mass.) 2005;16(5):595-7.
2005: Katherine A McGlynn; Susan S Devesa; Barry I Graubard; Philip E Castle
Increasing incidence of testicular germ cell tumors among black men in the United States.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5757-61.
2005: Michelle J Khan; Philip E Castle; Attila T Lorincz; Sholom Wacholder; Mark Sherman; David R Scott; Brenda B Rush; Andrew G. Glass; Mark Schiffman
The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.
Journal of the National Cancer Institute 2005;97(14):1072-9.
2005: Philip E Castle; Diane Solomon; Mark Schiffman; Cosette M Wheeler
Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities.
Journal of the National Cancer Institute 2005;97(14):1066-71.
2005: Mark Schiffman; Rolando Herrero; Rob DeSalle; Allan Hildesheim; Sholom Wacholder; Ana Cecilia Rodriguez; M Concepcion Bratti; Mark E Sherman; Jorge Morales; Diego Guillen; Mario Alfaro; Martha Hutchinson; Thomas C Wright; Diane Solomon; Zigui Chen; John E Schussler; Philip E Castle; Robert D Burk
The carcinogenicity of human papillomavirus types reflects viral evolution.
Virology 2005;337(1):76-84.
2005: Philip E Castle; Mark Schiffman; Rolando Herrero; Allan Hildesheim; Ana Cecilia Rodriguez; M Concepcion Bratti; Mark E Sherman; Sholom Wacholder; Robert E Tarone; Robert D Burk
A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica.
The Journal of infectious diseases 2005;191(11):1808-16.
2005: Rolando Herrero; Philip E Castle; Mark Schiffman; M Concepcion Bratti; Allan Hildesheim; Jorge Morales; Mario Alfaro; Mark E Sherman; Sholom Wacholder; Sabrina Chen; Ana Cecilia Rodriguez; Robert D Burk
Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica.
The Journal of infectious diseases 2005;191(11):1796-807.
2005: Ligia A Pinto; Philip E Castle; Richard B S Roden; Clayton D Harro; Douglas Lowy; John T Schiller; Dora Wallace; Marcus Williams; William Kopp; Ian H Frazer; Jay A Berzofsky; Allan Hildesheim
HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood.
Vaccine 2005;23(27):3555-64.
2005: Philip E Castle; Mark Schiffman; David R Scott; Mark E Sherman; Andrew G. Glass; Brenda B Rush; John E Schussler; Sholom Wacholder; Attila T Lorincz
Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(5):1311-4.
2005: Kathleen McIntyre-Seltman; Philip E Castle; Richard S Guido; Mark Schiffman; Cosette M Wheeler
Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(5):1165-70.
2005: Andrew W Bergen; Ying Qi; Kashif A Haque; Robert A Welch; Montserrat Garcia-Closas; STEPHEN CHANOCK; Jimmie B Vaught; Philip E Castle
Effects of electron-beam irradiation on whole genome amplification.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(4):1016-9.
2005: Philip E Castle; Mariane Garcia-Meijide; E Blair Holladay; Ronald Chuke; Jay Payne; Amanda Long; Heather Siefers; Franklin Demuth; Attila T Lorincz
A novel filtration-based processing method of liquid cytology specimens for human papillomavirus DNA testing by hybrid capture II.
American journal of clinical pathology 2005;123(2):250-5.
2005: Philip E Castle; Mark Schiffman; Rolando Herrero; Allan Hildesheim; Ana Cecilia Rodriguez; M Concepcion Bratti; Sholom Wacholder; Hortense Kendal; Anne M Breheny; Andrew Prior; Ruth Pfeiffer; Robert D Burk
PCR testing of pooled longitudinally collected cervical specimens of women to increase the efficiency of studying human papillomavirus infection.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(1):256-60.
2004: Philip E Castle; Mark Schiffman; Cosette M Wheeler
Hybrid capture 2 viral load and the 2-year cumulative risk of cervical intraepithelial neoplasia grade 3 or cancer.
American journal of obstetrics and gynecology 2004;191(5):1590-7.
2004: Philip E Castle; Cosette M Wheeler; Diane Solomon; Mark Schiffman; Cheri L Peyton
Interlaboratory reliability of Hybrid Capture 2.
American journal of clinical pathology 2004;122(2):238-45.
2004: Philip E Castle; Mark Schiffman; M Concepcion Bratti; Allan Hildesheim; Rolando Herrero; Martha L Hutchinson; Ana Cecilia Rodriguez; Sholom Wacholder; Mark E Sherman; Hortense Kendall; Raphael P Viscidi; Jose Jeronimo; John E Schussler; Robert D Burk
A population-based study of vaginal human papillomavirus infection in hysterectomized women.
The Journal of infectious diseases 2004;190(3):458-67.
2004: Philip E Castle
Beyond human papillomavirus: the cervix, exogenous secondary factors, and the development of cervical precancer and cancer.
Journal of lower genital tract disease 2004;8(3):224-30.
2004: Diana V Pastrana; Christopher B Buck; Yuk-Ying S Pang; Cynthia D Thompson; Philip E Castle; Peter C FitzGerald; Susanne Krüger-Kjaer; Douglas Lowy; John T Schiller
Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.
Virology 2004;321(2):205-16.
2004: Ana Cecilia Rodríguez; Lidia Ana Morera; Concepción Bratti; Rolando Herrero; J Thomas Cox; Jorge Morales; Mario Alfaro; Martha Hutchinson; Philip E Castle; Allan Hildesheim; Mark Schiffman
Performance of direct visual inspection of the cervix with acetic acid and magnification in a previously screened population.
Journal of lower genital tract disease 2004;8(2):132-8.
2004: Philip E Castle; Ana Cecilia Rodriguez; Frederick P Bowman; Rolando Herrero; Mark Schiffman; M Concepcion Bratti; Lidia Ana Morera; Danny Schust; Peggy A Crowley-Nowick; Allan Hildesheim
Comparison of ophthalmic sponges for measurements of immune markers from cervical secretions.
Clinical and diagnostic laboratory immunology 2004;11(2):399-405.
2004: Raphael P Viscidi; Mark Schiffman; Allan Hildesheim; Rolando Herrero; Philip E Castle; M Concepcion Bratti; Ana Cecilia Rodriguez; Mark E Sherman; Sophia Wang; Barbara Clayman; Robert D Burk
Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(2):324-7.
2003: Philip E Castle; Terry M Phillips; Allan Hildesheim; Rolando Herrero; M Concepcion Bratti; Ana Cecilia Rodríguez; Lidia Ana Morera; Ruth Pfeiffer; Martha L Hutchinson; Ligia A Pinto; Mark Schiffman
Immune profiling of plasma and cervical secretions using recycling immunoaffinity chromatography.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(12):1449-56.
2003: Ana Cecilia Rodríguez; Philip E Castle; Jennifer Smith; Concepción Bratti; Allan Hildesheim; Mark Schiffman; Raphael P Viscidi; Robert D Burk; R L Ashley; Xavier Castellsagué; Rolando Herrero
A population based study of herpes simplex virus 2 seroprevalence in rural Costa Rica.
Sexually transmitted infections 2003;79(6):460-5.
2003: Jose Jeronimo; Philip E Castle; Rolando Herrero; Robert D Burk; Mark Schiffman
HPV testing and visual inspection for cervical cancer screening in resource-poor regions.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2003;83(3):311-3.
2003: Sophia S Wang; Mark Schiffman; Tammy Shields; Rolando Herrero; Allan Hildesheim; M Concepcion Bratti; Mark E Sherman; Ana Cecilia Rodriguez; Philip E Castle; Jorge Morales; Mario Alfaro; T Wright; S Chen; Barbara Clayman; Robert D Burk; Raphael P Viscidi
Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10000 women in Costa Rica.
British journal of cancer 2003;89(7):1248-54.
2003: Kerstin Heselmeyer-Haddad; Viktor Janz; Philip E Castle; Nadia Chaudhri; Nicole White; Kim Wilber; Larry E Morrison; Gert Auer; Frances H Burroughs; Mark E Sherman; Thomas Ried
Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia.
The American journal of pathology 2003;163(4):1405-16.
2003: Philip E Castle; Attila T Lorincz; David R Scott; Mark E Sherman; Andrew G. Glass; Brenda B Rush; Sholom Wacholder; Robert D Burk; M Michele Manos; John E Schussler; Paul Macomber; Mark Schiffman
Comparison between prototype hybrid capture 3 and hybrid capture 2 human papillomavirus DNA assays for detection of high-grade cervical intraepithelial neoplasia and cancer.
Journal of clinical microbiology 2003;41(9):4022-30.
2003: Philip E Castle; Montserrat Garcia-Closas; Tracie Franklin; STEPHEN CHANOCK; Vinita Puri; Robert Welch; Nathaniel Rothman; Jimmie B Vaught
Effects of electron-beam irradiation on buccal-cell DNA.
American journal of human genetics 2003;73(3):646-51.
2003: Mark Schiffman; Philip E Castle
Human papillomavirus: epidemiology and public health.
Archives of pathology & laboratory medicine 2003;127(8):930-4.
2003: Ligia A Pinto; Jessica Edwards; Philip E Castle; Clayton D Harro; Douglas Lowy; John T Schiller; Dora Wallace; William Kopp; Joseph W Adelsberger; Michael Baseler; Jay A Berzofsky; Allan Hildesheim
Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.
The Journal of infectious diseases 2003;188(2):327-38.
2003: Jose Jeronimo; Philip E Castle; Rolando Herrero; Mark E Sherman; M Concepcion Bratti; Allan Hildesheim; Mario Alfaro; Jorge Morales; Martha L Hutchinson; Robert D Burk; Attila Lorincz; Sholom Wacholder; Ana Cecilia Rodríguez; Mark Schiffman
Right-sided ectocervical lesions may be associated with false-negative cytology among women with histologic cervical intraepithelial neoplasia 2 or 3.
Journal of lower genital tract disease 2003;7(3):175-83.
2003: Philip E Castle; Carlos Escoffery; Julius Schachter; Carole Rattray; Mark Schiffman; Jeanne Moncada; Karlyn Sugai; Claudette Brown; Beverley Cranston; Barrie Hanchard; Joel Palefsky; Robert D Burk; Martha L Hutchinson; Howard D Strickler
Chlamydia trachomatis, herpes simplex virus 2, and human T-cell lymphotrophic virus type 1 are not associated with grade of cervical neoplasia in Jamaican colposcopy patients.
Sexually transmitted diseases 2003;30(7):575-80.
2003: Philip E Castle; Diane Solomon; Allan Hildesheim; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Ana Cecilia Rodriguez; Mario Alfaro; Martha L Hutchinson; S Terence Dunn; Jane Kuypers; Mark Schiffman
Stability of archived liquid-based cervical cytologic specimens.
Cancer 2003;99(2):89-96.
2003: Philip E Castle; Anna R Giuliano
Chapter 4: Genital tract infections, cervical inflammation, and antioxidant nutrients--assessing their roles as human papillomavirus cofactors.
Journal of the National Cancer Institute. Monographs 2003;(31):29-34.
2003: Mark E Sherman; Attila T Lorincz; David R Scott; Sholom Wacholder; Philip E Castle; Andrew G. Glass; Iwona Mielzynska-Lohnas; Brenda B Rush; Mark Schiffman
Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
Journal of the National Cancer Institute 2003;95(1):46-52.
2002: Philip E Castle; Sholom Wacholder; Mark E Sherman; Attila T Lorincz; Andrew G. Glass; David R Scott; Brenda B Rush; Franklin Demuth; Mark Schiffman
Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women.
Cancer 2002;95(10):2145-51.
2002: Allan Hildesheim; Rick L Ryan; Elizabeth Rinehart; Sonali Nayak; Dora Wallace; Philip E Castle; Shelley Niwa; William Kopp
Simultaneous measurement of several cytokines using small volumes of biospecimens.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(11):1477-84.
2002: Philip E Castle; Mark Schiffman; Robert D Burk; Sholom Wacholder; Allan Hildesheim; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Attila T Lorincz
Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(11):1394-9.
2002: Philip E Castle; Mark Schiffman; Patti Gravitt; Hortense Kendall; Stacy Fishman; Huali Dong; Allan Hildesheim; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Attila T Lorincz; John E Schussler; Robert D Burk
Comparisons of HPV DNA detection by MY09/11 PCR methods.
Journal of medical virology 2002;68(3):417-23.
2002: Mark Schiffman; Cosette M Wheeler; Philip E Castle
Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalities.
The Journal of infectious diseases 2002;186(8):1169-72.
2002: Philip E Castle; Sholom Wacholder; Attila T Lorincz; David R Scott; Mark E Sherman; Andrew G. Glass; Brenda B Rush; John E Schussler; Mark Schiffman
A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women.
Journal of the National Cancer Institute 2002;94(18):1406-14.
2002: Attila T Lorincz; Philip E Castle; Mark E Sherman; David R Scott; Andrew G. Glass; Sholom Wacholder; Brenda B Rush; Patti Gravitt; John E Schussler; Mark Schiffman
Viral load of human papillomavirus and risk of CIN3 or cervical cancer.
Lancet 2002;360(9328):228-9.
2002: Philip E Castle; Attila T Lorincz; Iwona Mielzynska-Lohnas; David R Scott; Andrew G. Glass; Mark E Sherman; John E Schussler; Mark Schiffman
Results of human papillomavirus DNA testing with the hybrid capture 2 assay are reproducible.
Journal of clinical microbiology 2002;40(3):1088-90.
2002: Philip E Castle; Tammy Shields; Reinhard Kirnbauer; M Michele Manos; Robert D Burk; Andrew G. Glass; David R Scott; Mark E Sherman; Mark Schiffman
Sexual behavior, human papillomavirus type 16 (HPV 16) infection, and HPV 16 seropositivity.
Sexually transmitted diseases 2002;29(3):182-7.
2002: Philip E Castle; Allan Hildesheim; Frederick P Bowman; Howard D Strickler; Joan L Walker; Terri Pustilnik; Robert P Edwards; Peggy A Crowley-Nowick
Cervical concentrations of interleukin-10 and interleukin-12 do not correlate with plasma levels.
Journal of clinical immunology 2002;22(1):23-7.
2001: Philip E Castle; S L Hillier; L K Rabe; Allan Hildesheim; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Robert D Burk; Ana Cecilia Rodriguez; Mario Alfaro; Martha L Hutchinson; Jorge Morales; Mark Schiffman
An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(10):1021-7.
2001: Philip E Castle; T R Zemlo; Robert D Burk; D R Scott; Mark E Sherman; Attila T Lorincz; Robert J Kurman; Andrew G. Glass; Brenda B Rush; K L Liaw; Mark Schiffman
Cervical HPV DNA detection as a predictor of a recurrent SIL diagnosis among untreated women.
Journal of lower genital tract disease 2001;5(3):138-43.
2001: Allan Hildesheim; Rolando Herrero; Philip E Castle; Sholom Wacholder; M Concepcion Bratti; Mark E Sherman; Attila T Lorincz; Robert D Burk; Jorge Morales; Ana Cecilia Rodriguez; K Helgesen; Mario Alfaro; Martha Hutchinson; I Balmaceda; M Greenberg; Mark Schiffman
HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica.
British journal of cancer 2001;84(9):1219-26.